Chinese english Germany Japanese Korea

B-1

B-1 Struktur
11120-78-8
CAS-Nr.
11120-78-8
Englisch Name:
B-1
Synonyma:
B-1;Bp35;CVID5;Nancy;Ly-44;LEU-16;B-1(binder);B-lymphocyte surface antigen B1;Leukocyte surface antigen Leu-16;Elab Fluor? Violet 450 Anti-Human CD20 Antibody[2H7
CBNumber:
CB02314356
Summenformel:
Molgewicht:
0
MOL-Datei:
Mol file
Request For Quotation

B-1 Eigenschaften

Sicherheit

B-1 Chemische Eigenschaften,Einsatz,Produktion Methoden

B-1 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

B-1 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 13)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
ATK CHEMICAL COMPANY LIMITED 		+undefined-21-51877795
ivan@atkchemical.com China 33024 60
Zhengzhou Acme Chemical Co., Ltd. 0371-63315541 13323832564
 3001332135@qq.com China 9946 58
Nanjing Zhiyan Technology Co., Ltd. 15365097539
 877997991@qq.com China 1543 58
Shanghai Yunfu Nano Technology Co., Ltd 18964169089
 yfnano@126.com China 4546 58
Organtec Ltd 010-89719903 18511074324
 danlismi@outlook.com China 1334 58
Xi'an Kezhan Biotechnology Co., Ltd. 18729005399
 78282739@qq.com China 2302 58
JCRB Cell Bank 18777141920
 fisilsorders@fujifilm.com China 1412 58
Hangzhou Beishengyuan Biotechnology Co., Ltd 0571-15068777134 15068777134
 1289372011@qq.com China 4493 58
Beijing dtftchem Technology Co., Ltd. 13651141086
dtftchem@sina.com China 3380 62
Guangzhou Shunping Biotechnology Co., Ltd. 17264149895
CHINA 123 58
  • B-1
  • B-1(binder)
  • Nancy
  • (5Z,5'Z)-5,5'-((5'',5'''''-(4,8-bis(4-((2-ethylhexyl)thio)phenyl)benzo[1,2-b:4,5-b']dithiophene-2,6-diyl)bis(3',3''-dihexyl-[2,2':5',2''-terthiophene]-5'',5-diyl))bis(methanylylidene))bis(3-butyl-2-thioxothiazolidin-4-one)
  • Elab Fluor? Violet 450 Anti-Human CD20 Antibody[2H7
  • Elab Fluor? Red 780 Anti-Human CD20 Antibody[BCA/B20
  • B-lymphocyte surface antigen B1
  • Bp35
  • CVID5
  • LEU-16
  • Leukocyte surface antigen Leu-16
  • Ly-44
  • 11120-78-8
Copyright 2019 © ChemicalBook. All rights reserved